Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krainer

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Targets|February 14, 2008
Targeting signaling pathways in ovarian cancerJ Reibenwein, M Krainer
Arhiv Za Higijenu Rada I Toksikologiju|January 1, 1974
[Determination and decrease of impurities and humic acids in the river Sava near Zagreb]Z Sljivarić, M Krainer, Z Boban
Geburtshilfe Und Frauenheilkunde|July 1, 1995
[Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation]M Krainer, N Zojer, C Mannhalter
Wiener Klinische Wochenschrift|January 1, 1994
[Germ cell tumors of the testis]M Krainer, I Kührer, C Kratzik
Stem Cells (Dayton, Ohio)|August 1, 1995
Increase of bone marrow cellularity during erythropoietin treatment in myelomaH Ludwig, A Chott, E Fritz, et al.
Archives of Pathology & Laboratory Medicine|June 26, 1999
Influence of etoposide on the retention of radiolabeled low-density lipoprotein in the arterial wallM Krainer, M Rodrigues, C ZielinskiMD, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Failure to confirm presence of SV40 sequences in human tumoursM Krainer, T Schenk, C C Zielinski, et al.
Blood|June 15, 1991
Interleukin-6 is a prognostic factor in multiple myelomaH Ludwig, D M Nachbaur, E Fritz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 5, 2001
Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancerC Scholten, G Weinländer, M Krainer, et al.
Experimental Hematology|May 1, 1995
Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicityC Wiltschke, M Krainer, A Wagner, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Targets|February 14, 2008
Targeting signaling pathways in ovarian cancerJ Reibenwein, M Krainer
Arhiv Za Higijenu Rada I Toksikologiju|January 1, 1974
[Determination and decrease of impurities and humic acids in the river Sava near Zagreb]Z Sljivarić, M Krainer, Z Boban
Geburtshilfe Und Frauenheilkunde|July 1, 1995
[Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation]M Krainer, N Zojer, C Mannhalter
Wiener Klinische Wochenschrift|January 1, 1994
[Germ cell tumors of the testis]M Krainer, I Kührer, C Kratzik
Stem Cells (Dayton, Ohio)|August 1, 1995
Increase of bone marrow cellularity during erythropoietin treatment in myelomaH Ludwig, A Chott, E Fritz, et al.
Archives of Pathology & Laboratory Medicine|June 26, 1999
Influence of etoposide on the retention of radiolabeled low-density lipoprotein in the arterial wallM Krainer, M Rodrigues, C ZielinskiMD, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Failure to confirm presence of SV40 sequences in human tumoursM Krainer, T Schenk, C C Zielinski, et al.
Blood|June 15, 1991
Interleukin-6 is a prognostic factor in multiple myelomaH Ludwig, D M Nachbaur, E Fritz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 5, 2001
Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancerC Scholten, G Weinländer, M Krainer, et al.
Experimental Hematology|May 1, 1995
Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicityC Wiltschke, M Krainer, A Wagner, et al.
Pageof 5